0000899243-21-014210.txt : 20210331
0000899243-21-014210.hdr.sgml : 20210331
20210331164029
ACCESSION NUMBER: 0000899243-21-014210
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210325
FILED AS OF DATE: 20210331
DATE AS OF CHANGE: 20210331
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zordani Richard A. Jr.
CENTRAL INDEX KEY: 0001827180
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31791
FILM NUMBER: 21794022
MAIL ADDRESS:
STREET 1: 467 N. COUNTRY RIDGE CT.
CITY: LAKE ZURICH
STATE: IL
ZIP: 60047
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GALECTIN THERAPEUTICS INC
CENTRAL INDEX KEY: 0001133416
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043562325
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD
STREET 2: SUITE 240
CITY: NORCROSS
STATE: GA
ZIP: 30071
BUSINESS PHONE: 678-620-3186
MAIL ADDRESS:
STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD
STREET 2: SUITE 240
CITY: NORCROSS
STATE: GA
ZIP: 30071
FORMER COMPANY:
FORMER CONFORMED NAME: PRO PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010612
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-25
0
0001133416
GALECTIN THERAPEUTICS INC
GALT
0001827180
Zordani Richard A. Jr.
C/O GALECTIN THERAPEUTICS INC. 4960
PEACHTREE INDUSTRIAL BLVD., STE 240
NORCROSS,
GA
30071
1
0
0
0
Stock option (right to buy)
2.11
2021-03-25
4
A
0
40000
0.00
A
2031-03-25
Common Stock
40000
40000
D
Stock option (right to buy)
2.11
2021-03-25
4
A
0
70000
0.00
A
2031-03-25
Common Stock
70000
70000
D
The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan.
Such options vest 100% on March 31, 2022.
Such options vest when (i) the Company has received the interim results of its NAVIGATE clinical trial and (ii) makes a public announcement that it has received the interim results.
(1) The reporting person is president and director of Ed Uihlein Family Foundation, a not-for-profit corporation. The reporting person has no pecuniary interest in the shares, however, he shares voting and dispositive power over the shares and, therefore, remains the beneficial owner of the shares solely for the purposes of Section 13(d) of the Securities Exchange Act of 1934.
/s/ Jack W. Callicutt, by power of attorney
2021-03-29